Identification of multiple serine to asparagine sequence variation sites in an intended copy product of LUCENTIS® by mass spectrometry
Open Access
- 8 September 2017
- journal article
- other
- Published by Taylor & Francis in mAbs
- Vol. 9 (8) , 1337-1348
Abstract
Patent expiration of first-generation biologics and the high cost of innovative biologics are 2 drivers for the development of biosimilar products. There are, however, technical challenges to the production of exact copies of such large molecules. In this study, we performed a head-to-head comparison between the originator anti-VEGF-A Fab product LUCENTIS® (ranibizumab) and an intended copy product using an integrated analytical approach. While no differences could be observed using size-exclusion chromatography, capillary electrophoresis-sodium dodecyl sulfate and potency assays, different acidic peaks were identified with cation ion exchange chromatography and capillary zone electrophoresis. Further investigation of the intact Fab, subunits and primary sequence with mass spectrometry demonstrated the presence of a modified light chain variant in the intended copy product batches. This variant was characterized with a mass increase of 27.01 Da compared to the originator sequence and its abundance was estimated in the range of 6–9% of the intended copy product light chain. MS/MS spectra interrogation confirmed that this modification relates to a serine to asparagine sequence variant found in the intended copy product light chain. We demonstrated that the integration of high-resolution and sensitive orthogonal technologies was beneficial to assess the similarity of an originator and an intended copy product.Keywords
This publication has 41 references indexed in Scilit:
- Eliminating tyrosine sequence variants in CHO cell lines producing recombinant monoclonal antibodiesBiotechnology and Bioengineering, 2012
- Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized ApproachPLOS ONE, 2012
- Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibodyJournal of Chromatography B, 2011
- Detecting low level sequence variants in recombinant monoclonal antibodiesmAbs, 2010
- Discovery and Investigation of Misincorporation of Serine at Asparagine Positions in Recombinant Proteins Expressed in Chinese Hamster Ovary CellsJournal of Biological Chemistry, 2009
- Identification of Codon-Specific Serine to Asparagine Mistranslation in Recombinant Monoclonal Antibodies by High-Resolution Mass SpectrometryAnalytical Chemistry, 2009
- Challenges in monoclonal antibody-based therapiesAnnals of Medicine, 2009
- High-level Misincorporation of Lysine for Arginine at AGA Codons in a Fusion Protein Expressed inEscherichia coliJournal of Molecular Biology, 1996
- High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene productGene, 1989
- Mistranslation in IGF-1 during over-expression of the protein in Escherichia coli using a synthetic gene containing low frequency codonsBiochemical and Biophysical Research Communications, 1988